MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition

Molecular and Cellular Biology

Volumn 33, Issue 10, 2013, Pages 1956-1964

  Wang, Li ^a   Jia, Xiao Jian ^a   Jiang, Hua Jun ^a   Du, Yu ^a   Yang, Fan ^a   Si, Shu Yi ^a   Hong, Bin ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA; MICRORNA 185; MICRORNA 223; MICRORNA 96; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG; CHOLESTEROL; MIRN185 MICRORNA, HUMAN; MIRN223 MICRORNA, HUMAN; MIRN96 MICRORNA, HUMAN; RENILLA LUCIFERIN 2 MONOOXYGENASE; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; HUMAN; HUMAN CELL; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; BLOOD; CELL STRAIN HEPG2; GENE EXPRESSION; GENETICS; LIVER; MACROPHAGE; MALE; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REPORTER GENE; RNA INTERFERENCE;

MUS;

3' UNTRANSLATED REGIONS; ANIMALS; APOLIPOPROTEINS E; BASE SEQUENCE; CHOLESTEROL; CHOLESTEROL, HDL; GENE EXPRESSION; GENES, REPORTER; HEP G2 CELLS; HUMANS; LIVER; LUCIFERASES, RENILLA; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MICRORNAS; RNA INTERFERENCE; SCAVENGER RECEPTORS, CLASS B;

MLCS; MLOWN;

EID: 84878967914     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01580-12     Document Type: Article

References (49)

1. Boden WE. 2000. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am. J. Cardiol. 86:19L-22L.
2. Glomset JA, Norum KR. 1973. The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology. Adv. Lipid Res. 11:1-65.
3. Rosenson RS, Brewer HB, Jr, Davidson WS, Fayad ZA, Fuster V, Goldstein J, Hellerstein M, Jiang XC, Phillips MC, Rader DJ, Remaley AT, Rothblat GH, Tall AR, Yvan-Charvet L. 2012. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 125:1905-1919.
4. Goldstein JL, Brown MS. 1974. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J. Biol. Chem. 249:5153-5162.
5. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518 -520.
6. Krieger M. 1999. Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. Annu. Rev. Biochem. 68:523-558.
7. Calvo D, Vega MA. 1993. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J. Biol. Chem. 268:18929 -18935.
8. Trigatti BL, Krieger M, Rigotti A. 2003. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23:1732-1738.
9. Lopez D, McLean MP. 2006. Activation of the rat scavenger receptor class B type I gene by PPARalpha. Mol. Cell. Endocrinol. 251:67-77.
10. Malerod L, Juvet LK, Hanssen-Bauer A, Eskild W, Berg T. 2002. Oxysterol-activated LXRalpha/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Biochem. Biophys. Res. Commun. 299: 916-923.
11. Schoonjans K, Annicotte JS, Huby T, Botrugno OA, Fayard E, Ueda Y, Chapman J, Auwerx J. 2002. Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I. EMBO Rep. 3:1181-1187.
12. Lopez D, McLean MP. 1999. Sterol regulatory element-binding protein- 1a binds to cis elements in the promoter of the rat high density lipoprotein receptor SR-BI gene. Endocrinology 140:5669 -5681.
13. Zhang X, Moor AN, Merkler KA, Liu Q, McLean MP. 2007. Regulation of alternative splicing of liver scavenger receptor class B gene by estrogenand the involved regulatory splicing factors. Endocrinology 148:5295-5304.
14. Yesilaltay A, Kocher O, Rigotti A, Krieger M. 2005. Regulation of SR-BI-mediated high-density lipoprotein metabolism by the tissuespecific adaptor protein PDZK1. Curr. Opin. Lipidol. 16:147-152.
15. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
16. Olena AF, Patton JG. 2010. Genomic organization of microRNAs. J. Cell. Physiol. 222:540 -545.
17. Bao Y, Wang L, Xu Y, Yang Y, Si S, Cho S, Hong B. 2012. Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner. Atherosclerosis 223:152-159.
18. Bao Y, Yang Y, Wang L, Gao L, Jiang W, Si S, Hong B. 2009. Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells. Atherosclerosis 204: 127-135.
19. Chinetti G, Gbaguidi FG, Griglio S, Mallat Z, Antonucci M, Poulain P, Chapman J, Fruchart JC, Tedgui A, Najib-Fruchart J, Staels B. 2000. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101:2411-2417.
20. Leiva A, Verdejo H, Benitez ML, Martinez A, Busso D, Rigotti A. 2011. Mechanisms regulating hepatic SR-BI expression and their impact on HDL metabolism. Atherosclerosis 217:299 -307.
21. Hirano K, Ikegami C, Tsujii K, Zhang Z, Matsuura F, Nakagawa-Toyama Y, Koseki M, Masuda D, Maruyama T, Shimomura I, Ueda Y, Yamashita S. 2005. Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism. Arterioscler. Thromb. Vasc. Biol. 25:2422-2427.
22. Shetty S, Eckhardt ER, Post SR, van der Westhuyzen DR. 2006. Phosphatidylinositol-3-kinase regulates scavenger receptor class B type I subcellular localization and selective lipid uptake in hepatocytes. Arterioscler. Thromb. Vasc. Biol. 26:2125-2131.
23. Guttilla IK, White BA. 2009. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J. Biol. Chem. 284: 23204-23216.
24. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, Mac-Menamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. 2005. Combinatorial microRNA target predictions. Nat. Genet. 37:495-500.
25. Thomas M, Lieberman J, Lal A. 2010. Desperately seeking microRNA targets. Nat. Struct. Mol. Biol. 17:1169 -1174.
26. Yesilaltay A, Daniels K, Pal R, Krieger M, Kocher O. 2009. Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice. PLoS One 4:e8103. doi: 10.1371/journal.pone.0008103.
27. Huby T, Doucet C, Dachet C, Ouzilleau B, Ueda Y, Afzal V, Rubin E, Chapman MJ, Lesnik P. 2006. Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues. J. Clin. Invest. 116:2767-2776.
28. Ji A, Meyer JM, Cai L, Akinmusire A, de Beer MC, Webb NR, van der Westhuyzen DR. 2011. Scavenger receptor SR-BI in macrophage lipid metabolism. Atherosclerosis 217:106 -112.
29. Yvan-Charvet L, Wang N, Tall AR. 2010. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler. Thromb. Vasc. Biol. 30:139 -143.
30. Lee RC, Feinbaum RL, Ambros V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854.
31. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G. 2000. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901-906.
32. Ambros V. 2004. The functions of animal microRNAs. Nature 431:350-355.
33. Belver L, Papavasiliou FN, Ramiro AR. 2011. MicroRNA control of lymphocyte differentiation and function. Curr. Opin. Immunol. 23:368-373.
34. Liu N, Olson EN. 2010. MicroRNA regulatory networks in cardiovascular development. Dev. Cell 18:510 -525.
35. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3:87-98.
36. Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Naar AM. 2010. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328:1566 -1569.
37. Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernandez-Hernando C. 2010. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328:1570-1573.
38. Ramirez CM, Davalos A, Goedeke L, Salerno AG, Warrier N, Cirera-Salinas D, Suarez Y, Fernandez-Hernando C. 2011. MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler. Thromb. Vasc. Biol. 31:2707-2714.
39. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. 2011. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13:423-433.
40. Hu Z, Shen WJ, Kraemer FB, Azhar S. 2012. MicroRNAs-125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B, type I (SR-BI) in steroidogenic cells. Mol. Cell. Biol. 10.1128/MCB.01002-12.
41. Zhang Z, Tang H, Wang Z, Zhang B, Liu W, Lu H, Xiao L, Liu X, Wang R, Li X, Wu M, Li G. 2011. MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma. Mol. Cancer 10:124.
42. Liu M, Lang N, Chen X, Tang Q, Liu S, Huang J, Zheng Y, Bi F. 2011. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett. 301:151-160.
43. Kuhn S, Johnson SL, Furness DN, Chen J, Ingham N, Hilton JM, Steffes G, Lewis MA, Zampini V, Hackney CM, Masetto S, Holley MC, Steel KP, Marcotti W. 2011. miR-96 regulates the progression of differentiation in mammalian cochlear inner and outer hair cells. Proc. Natl. Acad. Sci. U. S. A. 108:2355-2360.
44. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, Brummelkamp TR, Fleming MD, Camargo FD. 2008. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451:1125-1129.
45. Zhuang G, Meng C, Guo X, Cheruku PS, Shi L, Xu H, Li H, Wang G, Evans AR, Safe S, Wu C, Zhou B. 2012. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 125:2892-2903.
46. Xu XM, Qian JC, Deng ZL, Cai Z, Tang T, Wang P, Zhang KH, Cai JP. 2012. Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer. Oncol. Lett. 4:339 -345.
47. Lin H, Dai T, Xiong H, Zhao X, Chen X, Yu C, Li J, Wang X, Song L. 2010. Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One 5:e15797. doi:10.1371/journal.pone.0015797.
48. Li J, Guo Y, Liang X, Sun M, Wang G, De W, Wu W. 2012. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. J. Cancer Res. Clin. Oncol. 138:763-774.
49. Zeng X, Xiang J, Wu M, Xiong W, Tang H, Deng M, Li X, Liao Q, Su B, Luo Z, Zhou Y, Zhou M, Zeng Z, Shen S, Shuai C, Li G, Fang J, Peng S. 2012. Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma. PLoS One 7:e46367. doi:10.1371/journal.pone.0046367.